Quest Diagnostics, Inc. (DGX)

239.13 -1.67 (-0.69%) USD  |  NYSE  |  Sep 03, 15:44
More

Quest Diagnostics Cash and Short Term Investments (Quarterly) : 626.00M for June 30, 2026

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for DGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 626.00M
March 31, 2026 393.00M
December 31, 2025 420.00M
September 30, 2025 432.00M
June 30, 2025 319.00M
March 31, 2025 188.00M
December 31, 2024 549.00M
September 30, 2024 764.00M
June 30, 2024 271.00M
March 31, 2024 474.00M
December 31, 2023 686.00M
September 30, 2023 143.00M
June 30, 2023 126.00M
March 31, 2023 175.00M
December 31, 2022 315.00M
September 30, 2022 700.00M
June 30, 2022 790.00M
March 31, 2022 712.00M
December 31, 2021 872.00M
September 30, 2021 987.00M
June 30, 2021 560.00M
March 31, 2021 1.23B
December 31, 2020 1.158B
September 30, 2020 1.605B
June 30, 2020 988.00M
Date Value
March 31, 2020 342.00M
December 31, 2019 1.192B
September 30, 2019 434.00M
June 30, 2019 273.00M
March 31, 2019 464.00M
December 31, 2018 135.00M
September 30, 2018 263.00M
June 30, 2018 132.00M
March 31, 2018 124.00M
December 31, 2017 137.00M
September 30, 2017 350.00M
June 30, 2017 314.00M
March 31, 2017 367.00M
December 31, 2016 359.00M
September 30, 2016 406.00M
June 30, 2016 283.00M
March 31, 2016 128.00M
December 31, 2015 133.00M
September 30, 2015 123.00M
June 30, 2015 150.00M
March 31, 2015 974.00M
December 31, 2014 192.00M
September 30, 2014 170.00M
June 30, 2014 144.00M
March 31, 2014 144.00M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Labcorp Holdings, Inc. 141.80M
DaVita, Inc. 771.77M
OPKO Health, Inc. 300.76M
Psychemedics Corp. --
NeoGenomics, Inc. 145.54M